PRAME-AS lncRNA, regulated by MZF1, modulates PRAME expression and cell stemness
PLOS One · 2025
DOI: 10.1371/journal.pone.0331190 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Zahra Hosseininia und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biotechnology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Antigens, Neoplasm, Kruppel-Like Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ferdowsi University of Mashhad.
Abstract (Originalsprache)
PRAME is a member of the large cancer-testis antigens (CTA). In normal tissues, PRAME is mainly expressed in the testis. However, low levels of PRAME transcript are detected in the endometrium, ovary, and adrenal glands. Due to the tumor‐restricted expression of PRAME, some of its regulatory factors have been investigated; however, the role of lncRNAs remains unclear. In this study, we ablated the PRAME-AS gene and investigated the effects on PRAME expression, cell proliferation, migration, viability, and anchorage-independent growth. We further manipulated PRAME-AS expression through MZF1 overexpression and hypermethylation of its upstream regulatory region. Additionally, we assessed the ability of the PRAME locus regulatory region to drive PRAME-AS lncRNA transcription. Our findings show that PRAME-AS gene knockout diminishes PRAME transcript levels by about 37%. The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. We discovered that MZF1 induces PRAME expression approximately twofold and increases PRAME-AS transcript levels by more than threefold. We found that hypermethylation of the upstream regulatory sequence of PRAME-AS results in an approximately 50% reduction in PRAME transcripts and an 18.5% decrease in PRAME-AS transcript levels. Moreover, based on our EGFP reporter assay, we conclude that the regulatory region of the PRAME locus—without PRAME transcription—is insufficient to drive transcription of PRAME-AS in the antisense direction. Taken together, our data support the conclusion that PRAME-AS lncRNA acts as a regulator of PRAME transcript levels, and that MZF1—and the methylation status of a shared CpG island— influence the expression of both genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Biotechnology, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.
- Stem Cells and Regenerative Medicine Research Group, Research Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran.
- Department of Basic Sciences, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran.
ORCID-Profile: Hesam Dehghani
Förderung
- Ferdowsi University of Mashhad
Zitieren
APA
Hosseininia, Z., & Dehghani, H. (2025). PRAME-AS lncRNA, regulated by MZF1, modulates PRAME expression and cell stemness. PLOS One. https://doi.org/10.1371/journal.pone.0331190
Vancouver
Hosseininia Z, Dehghani H. PRAME-AS lncRNA, regulated by MZF1, modulates PRAME expression and cell stemness. PLOS One. 2025. doi:10.1371/journal.pone.0331190
BibTeX
@article{Hosseininia2025,
author = {Hosseininia, Zahra and Dehghani, Hesam},
title = {PRAME-AS lncRNA, regulated by MZF1, modulates PRAME expression and cell stemness},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0331190}
}
EUVIMED